GR3029286T3 - Stable liquid compositions of gamma interferon - Google Patents
Stable liquid compositions of gamma interferonInfo
- Publication number
- GR3029286T3 GR3029286T3 GR990400366T GR990400366T GR3029286T3 GR 3029286 T3 GR3029286 T3 GR 3029286T3 GR 990400366 T GR990400366 T GR 990400366T GR 990400366 T GR990400366 T GR 990400366T GR 3029286 T3 GR3029286 T3 GR 3029286T3
- Authority
- GR
- Greece
- Prior art keywords
- stable liquid
- gamma
- liquid compositions
- gamma interferon
- ifn
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6032793A | 1993-05-12 | 1993-05-12 | |
PCT/US1994/004928 WO1994026302A1 (en) | 1993-05-12 | 1994-05-04 | Stable liquid compositions of gamma interferon |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3029286T3 true GR3029286T3 (en) | 1999-05-28 |
Family
ID=22028807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR990400366T GR3029286T3 (en) | 1993-05-12 | 1999-02-03 | Stable liquid compositions of gamma interferon |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0697887B1 (el) |
JP (1) | JP4053586B2 (el) |
KR (1) | KR100330325B1 (el) |
CN (1) | CN1120724C (el) |
AT (1) | ATE173632T1 (el) |
AU (1) | AU683469B2 (el) |
CA (1) | CA2159602C (el) |
CZ (1) | CZ285389B6 (el) |
DE (1) | DE69414841T2 (el) |
DK (1) | DK0697887T3 (el) |
ES (1) | ES2126114T3 (el) |
FI (1) | FI111442B (el) |
GR (1) | GR3029286T3 (el) |
HK (1) | HK1008303A1 (el) |
HU (1) | HUT72980A (el) |
IL (1) | IL109350A (el) |
NO (1) | NO320069B1 (el) |
NZ (1) | NZ266354A (el) |
PL (1) | PL176079B1 (el) |
SK (1) | SK280958B6 (el) |
TW (1) | TW275585B (el) |
WO (1) | WO1994026302A1 (el) |
ZA (1) | ZA942955B (el) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2758154B2 (ja) * | 1995-04-06 | 1998-05-28 | エフ・ホフマン−ラ ロシユ アーゲー | インターフェロンを含む液体製剤 |
US6090781A (en) * | 1996-11-06 | 2000-07-18 | Genentech, Inc. | Stabilizing formulation for NGF |
US6964947B1 (en) | 1995-11-07 | 2005-11-15 | Genentech, Inc. | Stabilizing formulation for NGF |
KR100497087B1 (ko) * | 1995-11-07 | 2005-09-09 | 제넨테크, 인코포레이티드 | 신경성장인자의안정화조성물 |
JP3493866B2 (ja) * | 1995-12-27 | 2004-02-03 | ライオン株式会社 | 発泡性口腔用組成物 |
AR006598A1 (es) * | 1996-04-19 | 1999-09-08 | Merck Sharp & Dohme | "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación" |
EP0920306A2 (en) | 1996-07-12 | 1999-06-09 | Leukosite, Inc. | Chemokine receptor antagonists and methods of use therefor |
SK284989B6 (sk) * | 1996-12-24 | 2006-04-06 | Biogen, Inc. | Kvapalná kompozícia obsahujúca interferón a spôsob stabilizácie interferónu |
US20030190307A1 (en) | 1996-12-24 | 2003-10-09 | Biogen, Inc. | Stable liquid interferon formulations |
US6991790B1 (en) | 1997-06-13 | 2006-01-31 | Genentech, Inc. | Antibody formulation |
US6171586B1 (en) | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
US6221378B1 (en) * | 1998-02-10 | 2001-04-24 | Generex Pharmaceuticals Incorporated | Mixed micellar delivery system and method of preparation |
US7070799B1 (en) | 1998-02-10 | 2006-07-04 | Generex Pharmaceuticals, Inc. | Method for administering insulin to the buccal region |
US6017545A (en) * | 1998-02-10 | 2000-01-25 | Modi; Pankaj | Mixed micellar delivery system and method of preparation |
GB9803448D0 (en) * | 1998-02-18 | 1998-04-15 | Pharma Mar Sa | Pharmaceutical formulation |
AU4445201A (en) * | 2000-03-30 | 2001-10-08 | Generex Pharmaceuticals Inc. | Method for administering insulin to the buccal region |
AUPR381601A0 (en) * | 2001-03-19 | 2001-04-12 | Monash University | Method of treating respiratory conditions |
JP5052736B2 (ja) * | 2001-05-30 | 2012-10-17 | 中外製薬株式会社 | タンパク質製剤 |
EP1516627A1 (en) * | 2003-09-17 | 2005-03-23 | CONARIS research institute AG | Interferon-Gamma for the treatment of diseases associated with the NOD2 gene |
JP5137055B2 (ja) * | 2006-03-10 | 2013-02-06 | 塩野義製薬株式会社 | 安定化されたインターフェロン−γ組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0257956B2 (en) * | 1986-08-19 | 2000-11-22 | Genentech, Inc. | Use of polypeptide growth factors and cytokines for the manufacture of a device and of a dispersion |
PT88490B (pt) * | 1987-09-14 | 1992-11-30 | Novo Nordisk As | Processo para a preparacao de composicoes farmaceuticas para libertacao nao-enterica trans-mucosa contendo monossacaridos ou oligossacaridos |
IL88233A (en) * | 1987-11-03 | 1993-08-18 | Genentech Inc | Gamma interferon formulation |
-
1994
- 1994-04-19 IL IL10935094A patent/IL109350A/en not_active IP Right Cessation
- 1994-04-28 ZA ZA942955A patent/ZA942955B/xx unknown
- 1994-05-04 JP JP52552294A patent/JP4053586B2/ja not_active Expired - Lifetime
- 1994-05-04 SK SK1378-95A patent/SK280958B6/sk not_active IP Right Cessation
- 1994-05-04 CZ CZ952955A patent/CZ285389B6/cs not_active IP Right Cessation
- 1994-05-04 PL PL94311639A patent/PL176079B1/pl unknown
- 1994-05-04 CN CN94192046A patent/CN1120724C/zh not_active Expired - Lifetime
- 1994-05-04 AT AT94916004T patent/ATE173632T1/de active
- 1994-05-04 EP EP94916004A patent/EP0697887B1/en not_active Expired - Lifetime
- 1994-05-04 DK DK94916004T patent/DK0697887T3/da active
- 1994-05-04 DE DE69414841T patent/DE69414841T2/de not_active Expired - Lifetime
- 1994-05-04 KR KR1019950705034A patent/KR100330325B1/ko not_active IP Right Cessation
- 1994-05-04 WO PCT/US1994/004928 patent/WO1994026302A1/en active IP Right Grant
- 1994-05-04 NZ NZ266354A patent/NZ266354A/en not_active IP Right Cessation
- 1994-05-04 HU HU9503223A patent/HUT72980A/hu unknown
- 1994-05-04 CA CA002159602A patent/CA2159602C/en not_active Expired - Lifetime
- 1994-05-04 ES ES94916004T patent/ES2126114T3/es not_active Expired - Lifetime
- 1994-05-04 AU AU67822/94A patent/AU683469B2/en not_active Expired
- 1994-05-06 TW TW083104134A patent/TW275585B/zh not_active IP Right Cessation
-
1995
- 1995-10-27 FI FI955136A patent/FI111442B/fi not_active IP Right Cessation
- 1995-11-10 NO NO19954544A patent/NO320069B1/no not_active IP Right Cessation
-
1998
- 1998-07-20 HK HK98109265A patent/HK1008303A1/xx not_active IP Right Cessation
-
1999
- 1999-02-03 GR GR990400366T patent/GR3029286T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW275585B (el) | ||
TW272195B (el) | ||
UA34428C2 (uk) | Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки | |
UA32525C2 (uk) | Стійка до шлункового соку форма лікарського засобу на основі пантопразолу для орального введення | |
GEP20053473B (en) | High Potency Dihydroergotamine Compositions | |
UA32512C2 (uk) | Похідні ксантину, спосіб їх одержання, та фармацевтична композиція | |
IL103510A0 (en) | Pharmaceutical compositions containing antibodies for causing immunosuppression | |
PL309282A1 (en) | Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant | |
HU9203871D0 (en) | Pharmaceutical application of certain cistine derivatives | |
ES479423A1 (es) | Procedimiento para la preparacion de 2-2-tenoiltio-propio- nil-glicina. | |
GB2251188B (en) | Drug delivery system comprising a lysophosphoglycerolipid | |
MX9709453A (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion. | |
MY115795A (en) | Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them | |
UA32583C2 (uk) | Похідні арилтіоалкілтіопіридину | |
WO2001018039A3 (en) | INCREASED PRODUCTION OF INTERFERON-$g(a) | |
ZA9364B (en) | Pyridysulphonylure compound, processes for the preparation thereof, and pharmaceutical compositions containing it | |
ES8304924A1 (es) | Un procedimiento para la preparacion de nuevos derivados del acido glutamil-diaminopimelico que contiene una b-lactama. | |
ITRM920551A1 (it) | Composizioni farmaceutiche somministrabili per via intranasale contenenti calcitonina quale principio attivo. | |
IT1244601B (it) | Composizioni farmaceutiche per la somministrazione intranasale di calcitonina | |
JO1711B1 (en) | Therapeutic agents |